Lars Edvinsson
41 – 50 of 397
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
MEK/ERK/1/2 sensitive vascular changes coincide with retinal functional deficit, following transient ophthalmic artery occlusion
(
- Contribution to journal › Article
-
Mark
Perivascular neurotransmitters : Regulation of cerebral blood flow and role in primary headaches
(
- Contribution to journal › Article
-
Mark
C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system
(
- Contribution to journal › Article
-
Mark
Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)
(
- Contribution to journal › Scientific review
-
Mark
Rimegepant oral disintegrating tablet for migraine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model
(
- Contribution to journal › Article
-
Mark
Does inflammation have a role in migraine?
2019) In Nature Reviews Neurology(
- Contribution to journal › Debate/Note/Editorial
-
Mark
MEK1/2 inhibitor U0126, but not nimodipine, reduces upregulation of cerebrovascular contractile receptors after subarachnoid haemorrhage in rats
(
- Contribution to journal › Article
-
Mark
The changing faces of migraine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
(
- Contribution to journal › Article